Literature DB >> 20484420

Nonlaxative PET/CT colonography: feasibility, acceptability, and pilot performance in patients at higher risk of colonic neoplasia.

Stuart A Taylor1, Jamshed B Bomanji, Levi Manpanzure, Charlotte Robinson, Ashley M Groves, John Dickson, Nickolaos D Papathanasiou, Rebecca Greenhalgh, Peter J Ell, Steve Halligan.   

Abstract

UNLABELLED: CT colonography without bowel preparation is a safer and better-tolerated alternative to full laxation protocols, but comparative sensitivity and specificity are potentially reduced. Uptake of (18)F-FDG by colonic neoplasia is well described, and combining PET with nonlaxative CT colonography could improve accuracy. The purpose was to prospectively test the technical feasibility and acceptability of combined nonlaxative PET/CT colonography in patients at higher risk of colorectal neoplasia and to provide pilot data on diagnostic performance.
METHODS: Fifty-six patients (median age, 64 y; 30 women) at high risk of colonic neoplasia underwent nonlaxative PET/CT colonography with barium fecal tagging within 2 wk of scheduled colonoscopy. Colonic segmental distension was graded 1 (poor) to 3 (good). A radiologist, experienced in CT colonography, and nuclear medicine physician in consensus analyzed the datasets. The diagnostic performance for standalone CT colonography and combined PET/CT colonography was compared with the reference colonoscopy. Patient experience for 25 items (each scored from 1 to 7) pertaining to satisfaction, worry, and physical discomfort was canvassed after both PET/CT colonography and colonoscopy.
RESULTS: Distension was good in 298 of 334 segments (89%; 95% confidence interval [CI], 85%-92%). Patients experienced more physical discomfort during colonoscopy (median, 4; interquartile range [IQR], 2-7) than during PET/CT colonography (median, 5; IQR, 3-7; P = 0.03) and were more willing to undergo PET/CT colonography again (36/43 [84%; 95% CI, 73%-95%] vs. 31/43 [72%; 95% CI, 59%-86%]; P = 0.001). Twenty-one patients had 54 polyps according to colonoscopy (10 with at least 1 polyp >or=6 mm and 8 with at least 1 polyp >or=10 mm). Of 14 polyps 6 mm or greater, 12 (86%; 95% CI, 67%-100%) were (18)F-FDG-avid, including all those 10 mm or greater (mean standardized uptake value, 10.1). CT colonography sensitivity for polyps 6 mm or larger was 92.9% (95% CI, 79.4%-100%) and was not improved by the addition of PET. However, combined PET/CT colonography review improved per-patient positive predictive value for a polyp 10 mm or greater from 73% (95% CI, 39-92) to 100% (95% CI, 60-100).
CONCLUSION: In this feasibility study, simultaneous PET acquisition during nonlaxative CT colonography is technically feasible, is well tolerated, and potentially improves specificity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484420     DOI: 10.2967/jnumed.109.072728

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  7 in total

Review 1.  Positron emission tomography for benign and malignant disease.

Authors:  Anthony Visioni; Julian Kim
Journal:  Surg Clin North Am       Date:  2011-02       Impact factor: 2.741

Review 2.  Evidence review and status update on computed tomography colonography.

Authors:  Darren Boone; Steve Halligan; Stuart A Taylor
Journal:  Curr Gastroenterol Rep       Date:  2011-10

Review 3.  Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies.

Authors:  Otto S Lin; Richard A Kozarek; Michael Gluck; Geoffrey C Jiranek; Johannes Koch; Kris V Kowdley; Shayan Irani; Matthew Nguyen; Jason A Dominitz
Journal:  J Gen Intern Med       Date:  2012-06-15       Impact factor: 5.128

4.  [Importance of PET/CT for imaging of colorectal cancer].

Authors:  F G Meinel; N Schramm; A R Haug; A Graser; M F Reiser; C Rist
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

5.  Affibody-functionalized gold-silica nanoparticles for Raman molecular imaging of the epidermal growth factor receptor.

Authors:  Jesse V Jokerst; Zheng Miao; Cristina Zavaleta; Zhen Cheng; Sanjiv S Gambhir
Journal:  Small       Date:  2011-02-08       Impact factor: 13.281

Review 6.  Preoperative evaluation of colorectal cancer using CT colonography, MRI, and PET/CT.

Authors:  Shigeyoshi Kijima; Takahiro Sasaki; Koichi Nagata; Kenichi Utano; Alan T Lefor; Hideharu Sugimoto
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

7.  Correlation between glucose metabolism parameters derived from FDG and tumor TNM stages and metastasis-associated proteins in colorectal carcinoma patients.

Authors:  Mingyu Zhang; Jigang Yang; Hao Jiang; Huijie Jiang; Zhenchang Wang
Journal:  BMC Cancer       Date:  2021-03-09       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.